Value
8.6/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 9.7 |
| P/S | 10.0 |
| EV/EBITDA | 8.5 |
| Fwd P/E | 9.8 |
| PEG | 6.8 |
| Analyst target | 7.5 |
- ▸Forward P/E: 6.3x
- ▸PEG: 1.05
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
| Pillar | Expectation | Trend |
|---|---|---|
Universal Health Services trades at a forward P/E of 5.8x and ranks in the top decile of healthcare facility peers on value metrics, representing an unusually steep discount for a company generating consistent earnings beats in 3 of the last 4 quarters. Valuation breakdown | Forward P/E multiple expands toward 8x as the downtrend resolves and the deep discount attracts institutional accumulation over 12 months | →Stable |
| CounterFree cash flow represents only 43% of net income — a quality red flag — and the stock is in a confirmed downtrend, which can sustain a low multiple for extended periods until momentum reverses | ||
UHS beat earnings estimates in 3 of the last 4 quarters with a recent beat of 14.9% and an average surprise of 6.3%, while analysts see 48% upside to targets — one of the widest analyst upside gaps in the healthcare facility sector. Earnings | Earnings beats continue in at least 2 of the next 4 quarters and price advances toward the analyst target of $194 within 12 months | →Stable |
| CounterThe company recently missed one quarter and guidance is unknown, while an elevated put/call ratio of 2.17 signals the market is not aligned with the analyst bull case | ||
The stock is in a confirmed downtrend with the moving average slope at negative 1.0% per 30 days and a death cross in place, representing a hard momentum block that prevents a clean technical entry at current levels. Momentum breakdown | Price crosses back above the 200-day moving average and MA slope turns positive within 6 months, removing the death cross block | →Stable |
| CounterMACD is improving and the asymmetry ratio of 5.0 is among the highest in the dataset, suggesting that the fundamental case is strong enough to attract buyers who can tolerate near-term technical weakness | ||
The put/call ratio of 2.17 combined with implied volatility of 73% indicates options market participants are positioning heavily for continued downside, reflecting widespread pessimism that would need to unwind for the stock to re-rate toward analyst targets. Options | Put/call ratio falls below 1.0 as the death cross resolves and fundamental strength reasserts, allowing bearish hedges to unwind over 12 months | →Stable |
| CounterElevated put/call ratios at extreme levels can indicate capitulation rather than sustained bearish conviction, and the current reading of 2.17 has historically sometimes marked near-term bottoms | ||
CounterFree cash flow represents only 43% of net income — a quality red flag — and the stock is in a confirmed downtrend, which can sustain a low multiple for extended periods until momentum reverses
CounterThe company recently missed one quarter and guidance is unknown, while an elevated put/call ratio of 2.17 signals the market is not aligned with the analyst bull case
CounterMACD is improving and the asymmetry ratio of 5.0 is among the highest in the dataset, suggesting that the fundamental case is strong enough to attract buyers who can tolerate near-term technical weakness
CounterElevated put/call ratios at extreme levels can indicate capitulation rather than sustained bearish conviction, and the current reading of 2.17 has historically sometimes marked near-term bottoms
Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Component | Sub-score |
|---|---|
| P/E | 9.7 |
| P/S | 10.0 |
| EV/EBITDA | 8.5 |
| Fwd P/E | 9.8 |
| PEG | 6.8 |
| Analyst target | 7.5 |
| Component | Sub-score |
|---|---|
| ROE | 7.1 |
| ROA | 5.6 |
| Gross margin | 4.8 |
| Op margin | 4.5 |
| Net margin | 4.3 |
| Current ratio | 4.2 |
| FCF quality | 3.4 |
| Moat | 6.9 |
| Piotroski F | 8.9 |
| Component | Sub-score |
|---|---|
| Rev growth | 4.9 |
| EPS growth | 5.5 |
| Component | Sub-score |
|---|---|
| RSI | 2.8 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 6.0 |
| Volume | 5.4 |
| Component | Sub-score |
|---|---|
| Analyst rating | 7.4 |
| Price target | 8.9 |
| erm sentiment | 4.8 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
| Component | Sub-score |
|---|---|
| value rank | 8.6 |
| quality rank | 7.3 |
| growth rank | 6.3 |
| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 1.5 |
| 52w position | 2.9 |
| gap | 5.0 |
| Component | Sub-score |
|---|---|
| short interest | 7.0 |
| days to cover | 8.7 |
| volatility | 6.3 |
| put call | 5.2 |
| implied vol | 5.2 |
| beta | 6.7 |
| debt equity | 7.0 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 5.7 |
| dividend safety | 5.2 |
Maintain position. Not compelling to add more.
L4:PATH_F_HOLDnone
SetupRecovery — Death cross but MACD improving, RSI 72
EdgeCatalyst-Driven — Earnings in 24d with 3/4 beat streak
SuitabilityModerate — Balanced profile
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:6.8>=5.5. Top dim: Value at 8.6; weakest: Technical at 2.4. No conviction either direction.
The strongest dimensions are Value at 8.6, Sentiment at 7.2, and Momentum at 6.8; the weakest are Technical at 2.4, Insider at 5.0, and Growth at 5.2. The V9 engine cleared all gates with 2 warnings, producing an asymmetric reward-to-risk of 1.87 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifForward P/E falls below 4x without a corresponding earnings increase, indicating further fundamental deterioration
Trip ifEPS surprise falls below 0% in at least 3 of the next 4 quarters
Trip ifPrice drops below $133 stop-loss level, more than 8% below current $145.97
Trip ifPut/call ratio rises above 3.0 or implied volatility exceeds 100%